Detail Data
Volume (24h): 2,761,638 shares
P/E Ratio: /
Forward P/E: -1.62
EPS: -0.66 USD
Forward EPS: -4.66 USD
Number of Shares: 72,991,400 shares
Market Capitalization: 549,625,280.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Arvinas does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a buy recommendation for Arvinas stock. The current number of analysts covering this company is 18. The highest target price is 110 USD, while the lowest target price is 8 USD. The median target valuation set by analysts is 15 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Arvinas.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Arvinas stock is: buy
Number of Analysts: 18
Highest Target Price: 110 USD
Lowest Target Price: 8 USD
Median Target Price: 15 USD

Fundamental Indicators

Indicator Data
Total Revenue: 426,900,000.00 USD
Net Income: -46,600,000.00 USD
Price-to-Book (P/B): 0.83
PEG Ratio: /
Exchange: NasdaqGS
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 430
Country: United States

Where to Buy Arvinas Stock?

You can purchase Arvinas stock on the NasdaqGS under the ticker symbol: ARVN. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Arvinas Stock

Indicator Value
Company Revenue: 426,900,000.00 USD
EBITDA: -91,400,000.00 USD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -0.66 USD
Book Value Per Share: 9.04 USD
Total Cash: 954,300,032.00 USD
Total Cash per Share: 13.07 USD
Total Debt: 10,500,000.00 USD
Debt to Equity Ratio: 0.02
Quick Ratio 4.50
Current Ratio 4.58
Free Cash Flow -2,687,500.00 USD
Operating Cash Flow -250,700,000.00 USD
Gross Margins 100.00 %
EBITDA Margins -21.41 %
Operating Margins 37.82 %
Profit Margins -10.92 %
Return on Assets -5.4 %
Return on Equity -7.3 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 646.2 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 549,625,280.00 USD
Enterprise Value -394,174,848.00 USD
EV/Revenue -0.923
EV/EBITDA 4.313
Float Shares 67,943,305 shares
Shares Outstanding 72,991,400 shares
Held Percent Insiders 0.07 %
Held Percent Institutions 86.60 %
Shares Short 8,231,632
Shares Short Prior Month 7,726,869
Date Short Interest 2025-05-15
Short Percentage of Total Shares 11.28 %
Short Ratio 2.54
Beta 2.20
Short Percentage of Float 11.46 %
Implied Shares Outstanding 72,991,400

Frequently Asked Questions (FAQ)

According to our data, the company Arvinas does not pay dividends yet, even in 2025.

Arvinas shares are traded on the NasdaqGS stock exchange under the ticker: ARVN. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Arvinas shares is from a total of 18 analysts. The average target price prediction is 15 USD per share.

The total number of Arvinas shares on the exchange is 72,991,400.00 shares, which at the current market capitalization gives the company a total valuation of 549,625,280.00 USD.